Daniel Camardo
Director/Board Member at CommunityHealth NFP
Net worth: 1 141 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Aaron Cox | M | 41 | 8 years | |
| Kasey Rosado | F | 50 | 2 years | |
| Ellen Gurley | F | - | 1 years | |
| Michael DesJardin | M | 66 | 8 years | |
| Irina P. Konstantinovsky | F | 54 | 7 years | |
| Andy Pasternak | M | 53 | 5 years | |
| Karin Rosen | M | 57 | 4 years | |
| Jane Gonnerman | F | - | 3 years | |
| Keli Walbert | F | - | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Lehmann | M | 58 | 21 years | |
| Ismail Kola | M | 67 | 13 years | |
| Barry Moze | M | 70 | 8 years | |
| John Harrington | M | 56 | 27 years | |
| Ivor MacLeod | M | 63 | 2 years | |
| Katherine Kalin | F | 61 | 2 years | |
| Brian Beeler | M | 51 | 9 years | |
| Maia Hansen | F | 55 | 3 years | |
| Neema Mayhugh | M | 48 | 1 years | |
| Baiju R. Shah | M | 52 | 2 years | |
| Joseph Nolan | M | 61 | 1 years | |
| Robert Metz | M | - | 10 years | |
| Elizabeth Cermak | F | 66 |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | - |
| James Shannon | M | 67 | 6 years | |
| Mary Martin | M | - | 1 years | |
| Pascale Witz | F | 57 | 6 years | |
| Virinder Nohria | M | 70 | 3 years | |
| Jeff Randall | M | 80 | 15 years | |
| Susan Mahony | M | 59 | 4 years | |
| Ronald E. Pauli | M | 63 | 8 years | |
| Shao Lee Lin | M | 57 | 2 years | |
| Ron Oyston | M | 54 | 3 years | |
| petra Molan | F | - | 1 years | |
| Rob Ortmann | M | - | 1 years | |
| Javier Szwarcberg | M | 54 | 1 years | |
| James Glover | M | - | 2 years | |
| Elizabeth Thompson | M | 49 | - | |
| Jennifer T. Lee | F | - | - | |
| Michael Conick Hanley | M | 51 | 2 years | |
| Jörn Drappa | M | 60 | - | |
| David Happel | M | 62 | 2 years | |
| Tim Ayers | M | - | 3 years | |
| John J. Kody | M | - | 2 years | |
| David Kelly | M | 63 | 4 years | |
| Eric B. Mosbrooker | M | 46 | 2 years | |
| Mark Prygocki | M | 58 |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | 8 years |
| Patrick Ashe | M | 59 | - | |
| Keith S. Swenson | M | - | - | |
| Kenneth Traub | M | 62 | 1 years | |
| John B. Thomas | M | - | 2 years | |
| Hardy Kagimoto | M | 47 | 4 years | |
| Steven Pfeiffer | M | 48 | 1 years | |
| Robert Carey | M | 65 | 5 years | |
| Sherri Stewart | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 36 | 67.92% |
| United States | 17 | 32.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Daniel Camardo
- Personal Network